In this episode, Prof. Romero Ramos provides an overview of her presentation at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, and discusses the role of the immune system in Parkinson’s disease.
Read MoreIn this episode. Prof. Bas Bloem provides an overview of the topics covered in his lecture at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, and discusses how biomarkers may help us identify patients and select adequate therapeutic strategies.
Read MoreIn this episode, Dr. Hugo Morales interviews Dr. Bas Bloem and Dr. Victor Fung, co-authors of «The Wisdom of Our Mentors: Clinical Pearls in Movement Disorders,» who share clinical pearls and discuss how mentors’ and mentees’ interactions are at the center of mentorship in movement disorders and the MDS. Read the article
Read MoreProf. Paresh Doshi discusses with Dr. Sara Schaefer the short- and long-term outcomes of unilateral radiofrequency pallidotomy in focal and hemidystonia patients in this single-blind cohort study published in Movement Disorders Clinical Practice. Read the article
Read MoreDr. Michele Matarazzo interviews Dr. Robert Chen about the rapidly expanding applications of focused ultrasound-based neuromodulation in neurology, particularly in movement disorders, from tremor to Parkinson’s disease. Tune in to uncover the future and potential of non-invasive neurotherapies that are setting new standards in research and patient care.
Read MoreProf. Tiago Outeiro interviews Dr. Jing Zhang on his most recent paper in the Movement Disorder Journal on the erythrocytic alpha synuclein and the gut microbiome. Together they discuss alpha synuclein spreading pathology and the promising future of blood biomarkers for Parkinson’s disease. Journal CME is available until March 02, 2025 Read the article.
Read MoreDr. Jussi Sipilä joins Dr. Eduardo de Pablo-Fernandez to discuss the interesting findings of the article on mortality rate in Parkinson’s disease using nationwide data from multiple health registries in Finland. Read the article
Read More